Library > Country Reports



Meanwhile the country’s newly appointed minister of health has been audacious in radically reshuffling the rules of the game to place public healthcare provision “firmly on a pathway to sustainability.” “A corner has been turned and we are well on the way to…

With steady GDP growth, political stability and the best healthcare system in Latin America, Colombia’s life sciences industry has all the ingredients for success laid out before it. Indeed, with the domestic pharmaceutical market set to grow at a rate of around 7.3…

This report offers companies, investors, policymakers, and stakeholders crucial insight into Ireland; a nation that stands poised to cement its position as a premier pharmaceuticals power, not just within Europe, but globally. In addition to its blossoming R&D…

With an admirable legacy of excellence behind it, Austria’s healthcare and life science industry is poised to take the next step and help make the country a genuine hub for both its region and for Europe. Vienna is already fast establishing itself as Central…

This report offers companies, investors, policymakers, and stakeholders crucial insight into Singapore; a nation that has had to carve out its own niche as a global trade hub and gateway to the Asia-Pacific region to compete globally since declaring independence in 1965. In…

This report offers companies, investors, policymakers, and stakeholders crucial insight into the Czech Republic; a country transforming itself from merely a producer of cheap generics to the regional headquarters of some of the largest pharmaceutical companies in the world.…

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here